As we mark Volunteers’ Week, RNIB Scotland is proud to tell the story of one of our longstanding volunteers and community members, Bruce Christie (59). Bruce, who is from Westhill, was diagnosed with keratoconus in 2003, along with other minor...
Within the typical eye unit, there are lots of ‘Ophth’ job titles. We as ophthalmic professionals mostly know what these titles mean, but do our patients and junior staff? During my career I have had many and varied job titles,...
Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...
It is always nice to get a thank you card, especially so when it comes from someone at the tail end of an overbooked clinic who had waited patiently well past their appointed slot. Such was the case when I...
Ophthalmology specialty trainees are required to pass the refraction certificate exam within the first two years of training. If one passes this exam before entering a training programme, this can add two points to the portfolio during applications. In this...
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ScleralTattoo #BlackEye Scleral tattoos aren’t necessarily a new phenomenon. A quick google search will identify cases being in the news from...
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Can OCT predict Alzheimer’s disease? In 1986 Hinton et al. demonstrated evidence of optic nerve degeneration...
The connection between the eye and systemic diseases has been acknowledged for millenia. Historical records suggest that ancient civilisations had some understanding of the eye’s significance beyond its primary function in vision. For instance, in ancient Egypt, the ‘Eye of...
What have spinal and vision research got in common? More than you’d think. Dr Richard Eva. Funded by Fight for Sight, Dr Richard Eva came to vision from spinal cord research and is now co-lead on a project related to...
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
The UK currently spends £25 billion per year on ocular disease, and there is expected to be a 40% increase in those affected by visual impairment by 2050 [1]. To manage this demand, 82% of ophthalmology units across the UK...